Friday, April 28, 2017 8:49:38 AM
04/28/17 08:46:59 17.01 16.50 17.01 50
04/28/17 08:46:59 17.01 16.50 17.01 200
04/28/17 08:46:59 17.01 16.50 17.01 100
04/28/17 08:46:03 17.01 16.50 17.01 300
04/28/17 08:44:23 17.01 16.50 17.01 1,000
04/28/17 08:43:56 17.01 16.50 17.01 200
04/28/17 08:43:56 17.00 17.00 17.01 100
04/28/17 08:43:48 17.01 17.00 17.68 100
04/28/17 08:43:32 17.01 17.00 17.69 100
04/28/17 08:37:48 17.50 17.00 17.70 50
04/28/17 08:34:57 17.75 16.25 17.75 400
04/28/17 08:33:07 18.00 16.25 18.00 60
04/28/17 08:33:02 18.00 16.25 18.20 40
04/28/17 08:33:02 17.90 16.25 17.90 100
04/28/17 08:33:02 17.90 16.25 17.90 100
04/28/17 08:31:18 18.00 18.00 18.20 100
04/28/17 08:30:54 18.20 18.00 18.20 60
04/28/17 08:30:54 18.20 18.20 18.55 100
04/28/17 08:29:27 18.21 18.20 18.55 100
04/28/17 08:29:27 18.21 18.20 18.21 100
04/28/17 08:29:27 18.21 18.20 18.21 100
04/28/17 08:29:27 18.21 18.20 18.21 100
04/28/17 08:29:27 18.21 18.20 18.21 100
04/28/17 08:29:27 18.21 18.20 18.21 500
04/28/17 08:28:59 18.20 18.20 18.21 200
04/28/17 08:28:59 18.20 18.20 18.21 100
04/28/17 08:28:51 18.21 18.20 18.21 50
04/28/17 08:27:09 18.20 18.20 18.21 100
04/28/17 08:25:54 18.21 18.20 18.55 25
04/28/17 08:24:11 18.20 18.20 18.55 20
04/28/17 08:24:11 18.20 18.20 18.55 300
04/28/17 08:22:33 18.20 18.20 18.55 100
04/28/17 08:22:11 18.20 18.20 18.89 100
04/28/17 08:21:57 18.20 18.20 18.89 50
04/28/17 08:21:57 18.20 18.20 18.89 400
04/28/17 08:21:27 18.20 18.20 18.90 700
04/28/17 08:21:01 18.20 18.20 18.90 300
04/28/17 08:19:50 17.95 15.51 19.00 100
04/28/17 08:19:50 17.95 15.51 18.00 500
04/28/17 08:19:50 18.00 15.51 18.00 200
04/28/17 08:19:50 18.00 15.51 18.00 100
04/28/17 08:19:50 18.00 15.51 18.00 100
04/28/17 08:19:11 18.00 15.50 18.10 50
04/28/17 08:19:10 18.10 18.10 18.11 100
04/28/17 08:19:05 18.11 18.10 18.11 25
04/28/17 08:19:02 18.25 18.10 18.25 200
04/28/17 08:18:59 18.10 18.10 18.25 68
04/28/17 08:18:59 18.10 18.10 18.25 300
04/28/17 08:18:56 18.10 18.10 18.25 200
04/28/17 08:18:50 18.10 18.10 18.25 30
04/28/17 08:18:30 18.11 18.10 18.60 10
04/28/17 08:18:10 18.11 18.11 18.60 100
04/28/17 08:17:43 18.11 18.11 18.99 75
04/28/17 08:17:42 18.11 18.10 18.11 100
04/28/17 08:17:42 18.11 18.10 18.11 100
04/28/17 08:17:38 18.10 18.10 18.11 97
04/28/17 08:17:37 18.11 18.10 18.11 25
04/28/17 08:16:00 18.10 18.10 18.99 25
04/28/17 08:15:10 18.08 17.50 18.08 100
04/28/17 08:13:11 17.00 17.00 18.08 80
04/28/17 08:13:11 17.00 17.00 18.08 200
04/28/17 08:12:41 16.55 17.00 18.00 60
04/28/17 08:09:45 16.55 16.50 18.08 30
04/28/17 08:05:09 15.50 15.50 18.08 500
Recent SNPX News
- Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis • PR Newswire (US) • 06/26/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:03:21 PM
- Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery • PR Newswire (US) • 05/07/2024 01:00:00 PM
- Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing • PR Newswire (US) • 04/24/2024 01:15:00 PM
- Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics • PR Newswire (US) • 04/09/2024 01:15:00 PM
- Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing • PR Newswire (US) • 04/03/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:16:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 10:00:18 PM
- Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age-Related Diseases and Neurodegenerative Disorders • PR Newswire (US) • 12/19/2023 02:00:00 PM
- Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's • PR Newswire (US) • 12/06/2023 02:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/14/2023 10:05:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/13/2023 10:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 10:00:23 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/03/2023 09:00:19 PM
- Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology • PR Newswire (US) • 11/02/2023 01:00:00 PM
- Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease • PR Newswire (US) • 09/26/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 08:05:55 PM
- Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study • PR Newswire (US) • 09/07/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:00:40 PM
- Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis • PR Newswire (US) • 07/19/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 12:55:57 PM
- Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience • PR Newswire (US) • 07/13/2023 01:00:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM